BATTLE Program: Erlotinib in Previously Treated Subjects With Advanced NSCLC
Clinical trial NCT00410059 · COMPLETED
Trial details
- NCT number
- NCT00410059
- Sponsor
- M.D. Anderson Cancer Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2006-11-01
- Primary completion
- 2016-07-01
- Enrollment
- 59
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.